The global tinea pedis treatment market is on track for substantial growth, with projections indicating a rise from USD 1,496.3 million in 2024 to USD 2,484 million by 2034. This growth represents a ...
Although ibogaine gained popularity in the U.S. and Europe in the 1980s as a non-addictive treatment for drug dependency, it’s still classified as a Schedule I substance under the Controlled ...
About one in 300 people worldwide are affected by schizophrenia, but for decades treatment options have been both static and limited. If the FDA approves the twice-daily pill on Thursday ...
The global tinea pedis treatment market is on a robust growth trajectory, projected to reach a market value of USD 2,484 million by 2034, from an estimated USD 1,496.3 million in 2024. According to ...